Erika M Gaglione (Erika Gaglione)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

American journal of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, Chingiz Underbayev, Pamela L Tuma, Xin Tian, Lita A Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestner
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, Chingiz Underbayev, Pamela L Tuma, Xin Tian, Lita A Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestner
CD49d expression identifies a biologically distinct subtype of chronic lymphocytic leukemia with inferior progression-free survival on BTK inhibitor therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maissa Mhibik, Erika M Gaglione, David Eik, John Herrick, Janet Le, Inhye E Ahn, Christopher Chiu, Monica Wielgos-Bonvallet, Ida H Hiemstra, Esther Cw Breij, Jenny Chen, Edward B Reilly, Pearlie K Epling-Burnette, Edith Szafer Glusman, Clare Sun, Adrian Wiestner
Cytotoxicity of the CD3xCD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or Bcl-2 targeting. Blood advances (2023)
Deyi Zhang, Hailey M Harris, Jonathan Chen, Jennifer Toolan Judy, Gabriella James, Aileen Kelly, Joel McIntosh, Austin Tenn-McClellan, Eileen Rio Ambing, Ying Siow Tan, Hao Lu, Stefan Gajewski, Matthew C Clifton, Stephanie Yung, Daniel W Robbins, Mehdi Piroozia, Sigrid S Skånland, Erika M Gaglione, Maissa Mhibik, Chingiz Underbayev, Inhye Ahn, Clare Sun, Sarah E M Herman, Mark A Noviski, Adrian Wiestner
-----NRX-0492 Degrades Wildtype and C481 Mutant BTK and Demonstrates in vivo Activity in CLL Patient Derived Xenografts. Blood (2022)
Maria Joao Baptista, Sivasubramanian Baskar, Erika M Gaglione, Keyvan Keyvanfar, Inhye E Ahn, Adrian Wiestner, Clare Sun
Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
Arthur L Shaffer, James D Phelan, James Q Wang, DaWei Huang, George W Wright, Monica Kasbekar, Jaewoo Choi, Ryan M Young, Daniel E Webster, Yandan Yang, Hong Zhao, Xin Yu, Weihong Xu, Sandrine Roulland, Michele Ceribelli, Xiaohu Zhang, Kelli M Wilson, Lu Chen, Crystal McKnight, Carleen Klumpp-Thomas, Craig J Thomas, Björn Häupl, Thomas Oellerich, Zachary Rae, Michael C Kelly, Inhye E Ahn, Clare Sun, Erika M Gaglione, Wyndham H Wilson, Adrian Wiestner, Louis M Staudt
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors. Blood cancer discovery 2 (6) (2021)
Inhye E Ahn, Xin Tian, David Ipe, Mei Cheng, Maher Albitar, L Claire Tsao, Lei Zhang, Wanlong Ma, Sarah E M Herman, Erika M Gaglione, Susan Soto, James P Dean, Adrian Wiestner
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (6) (2020)
Christopher Pleyer, Xin Tian, Shakuntala Rampertaap, Rui Mu, Susan Soto, Jeanine Superata, Erika M Gaglione, Clare Sun, Jennifer Lotter, Maryalice Stetler-Stevenson, Constance M Yuan, Irina Maric, Stefania Pittaluga, Sergio Rosenzweig, Thomas Fleisher, Adrian Wiestner, Inhye E Ahn
A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia. American journal of hematology 95 (11) (2020)
Anfal Alsadhan, Jean Cheung, Michael Gulrajani, Erika M Gaglione, Pia Nierman, Ahmed Hamdy, Raquel Izumi, Elena Bibikova, Priti Patel, Clare Sun, Todd Covey, Sarah E M Herman, Adrian Wiestner
Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (12) (2020)